⌘K

Home/Filings/4/0001415889-24-024093

4//SEC Filing

KENYON LAWRENCE A 4

Accession 0001415889-24-024093

CIK 0001649989other

View on SEC.gov Company Profile

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 4:53 PM ET

Size

4.9 KB

Accession

0001415889-24-024093

Insider Transaction Report

Form 4

Period: 2024-09-26

Outlook Therapeutics, Inc.OTLK

KENYON LAWRENCE A

CFO and Secretary

Transactions

Purchase
Common Stock
2024-09-26$5.69/sh+5,000$28,446→ 5,946 total

Footnotes (1)

[F1]Reflects the Issuer's 1-for-20 reverse stock split effected on March 13, 2024.

Documents

1 file

4
form4-09302024_080919.xmlPrimary

Issuer

Outlook Therapeutics, Inc.

CIK 0001649989

Entity typeother

Related Parties

1

filerCIK 0001230484

Filing Metadata

Form type: 4
Filed: Sep 29, 8:00 PM ET
Accepted: Sep 30, 4:53 PM ET
Size: 4.9 KB

View on SEC.gov